TrueBlue (TBI) Tops Q2 EPS by 2c, Posts Strong Q3 Guidance
Tweet
Share
E-mailGet Alerts TBI Hot Sheet
Price: $9.94 -2.83%
Financial Fact:
Interest expense: -1.72M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Interest expense: -1.72M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
TrueBlue (NYSE: TBI) reported Q2 EPS of $0.20, $0.02 better than the analyst estimate of $0.18. Revenue for the quarter came in at $320 million versus the consensus estimate of $320.01 million.
TrueBlue sees Q3 2011 EPS of $0.27-$0.32, versus the consensus of $0.30. TrueBlue sees Q3 2011 revenue of $360-$370 million, versus the consensus of $349.24 million.
TrueBlue sees Q3 2011 EPS of $0.27-$0.32, versus the consensus of $0.30. TrueBlue sees Q3 2011 revenue of $360-$370 million, versus the consensus of $349.24 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
